08217.HK
Ju Fu Tang Biotech Holdings Co., Ltd
HKSE · Industrials · Engineering & Construction · HK
HKD 0.11
+0.88%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 52.9M | 37.6M | 36.2M | 35.1M | 104.6M |
| Cost of Revenue | 54.6M | 36.5M | 35.2M | 33.3M | 107.5M |
| Gross Profit | (1.8M) | 1.0M | 982.0K | 1.9M | (2.9M) |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 20.7M | 7.2M | 13.1M | 7.6M | 9.8M |
| General & Admin Expense | 5.5M | — | 9.4M | 7.6M | 5.8M |
| Selling & Marketing Expense | 3.6M | — | 3.8M | — | 4.0M |
| Other Expenses | (10.2M) | — | (6.9M) | 11.0M | (3.5M) |
| Total Operating Expenses | 15.6M | 7.2M | 6.2M | 18.6M | 6.4M |
| Cost and Expenses | 70.2M | 43.7M | 41.4M | 51.9M | 113.8M |
| Operating Income (EBIT) | (17.4M) | (6.2M) | (5.2M) | (16.7M) | (9.2M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 1.3M | 720.0K | 720.0K | 720.0K | 721.0K |
| Net Interest Income | (1.3M) | (720.0K) | (720.0K) | (720.0K) | (721.0K) |
| Other Non-Op Income/Expense | 38.9M | 29.5M | (720.0K) | (720.0K) | (721.0K) |
| Non-Operating Income (excl Interest) | (29.0M) | — | — | — | 3.4M |
| EBT (Pre-Tax Income) | 21.5M | 23.3M | (5.9M) | (17.4M) | (10.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | 21.5M | 23.3M | (5.9M) | (17.4M) | (10.0M) |
| Earnings from Cont. Ops | 21.5M | 23.3M | (5.9M) | (17.4M) | (10.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 21.5M | 23.3M | (5.9M) | (17.4M) | (10.0M) |
| Per Share | |||||
| Basic EPS | HK$0.07 | HK$0.08 | (HK$0.02) | (HK$0.06) | (HK$0.03) |
| Diluted EPS | HK$0.07 | HK$0.08 | (HK$0.02) | (HK$0.06) | (HK$0.03) |
| Revenue Per Share | HK$0.17 | HK$0.12 | HK$0.12 | HK$0.12 | HK$0.35 |
| Shares | |||||
| Basic Shares Outstanding | 303.1M | 301.9M | 301.9M | 301.9M | 301.9M |
| Diluted Shares Outstanding | 303.1M | 305.9M | 301.9M | 301.9M | 301.9M |
| Profitability Metrics | |||||
| EBITDA | 11.7M | (6.1M) | (5.1M) | (16.6M) | (9.1M) |
| D&A | 97.0K | 40.0K | 80.0K | 80.0K | 113.0K |
| EBIT | 11.6M | (6.2M) | (5.2M) | (16.7M) | (9.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026